Gross

Decentralized biobanking (de-bi) leverages blockchain technology to empower patient engagement in biospecimen research. Dr. Marielle Gross' team demonstrates proof-of-concept for engaging patients, physicians, and scientists in a dynamic research community. This prototype is a first step for advancing paradigm-shifting de-bi technology that provides unprecedented transparency and suggests new standards for equity and inclusion in biobanking.

Dr. Marielle Gross' study highlights pregnant people's perceptions of prenatal ultrasounds as an inherently valuable source of information and preparedness. 95% of participants desired information about abnormal sonographic findings, and 50% would consider pregnancy termination for anomalies. 

Breast/chestfeeding is beneficial for infants and parents, and stigmatization of substance use in pregnancy has been historically linked to punitive approaches with a disproportionate impact on minority populations. Dr. Marielle Gross advanced an empirically informed ethical analysis of this issue based on the current U.S. guidelines.

Read more: https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-022-00127-y